Conversation with The Cancer Letter ATOM Coalition sees patent sharing as key to overcoming scarcity of cancer drugs in LLMICs June 03, 2022Vol.48 No.22By Alice Tracey
Cancer History ProjectConversation with The Cancer LetterFree In 1998, a CML patient was out of options. Then she chanced into a treatment–Gleevec June 03, 2022Vol.48 No.22By Deborah Doroshow and Alexandria Carolan
FreeIn the Archives ASCO annual meetings through the years: A timeline of The Cancer Letter’s coverage June 03, 2022Vol.48 No.22
FreeGuest Editorial What cancer centers need to do in the wake of Buffalo, Uvalde shootings May 27, 2022Vol.48 No.21By Candace S. Johnson
FreeGuest Editorial Rob Winn on Buffalo massacre: “I grew up there. This is personal to me.” May 27, 2022Vol.48 No.21By Robert A. Winn
FreeGuest Editorial Heartbreak in South Texas: Seeing the Uvalde killings through the lens of Mays Cancer Center May 27, 2022Vol.48 No.21By Ruben A. Mesa
Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure May 27, 2022Vol.48 No.21By Paul Goldberg
Capitol Hill House Republicans seek information on “me-too” drugs developed in China May 27, 2022Vol.48 No.21By Alice Tracey
Capitol Hill Cancer groups ask for $4.1 billion increase for NIH, $850 million boost for NCI in FY23 May 27, 2022Vol.48 No.21By Alice Tracey
Book ReviewCancer History ProjectFree Craig Jordan’s “Tamoxifen Tales” chronicles a pathbreaking scientific career May 27, 2022Vol.48 No.21By Donald L. "Skip" Trump
